Cancer rates rose for women in some countries where extreme heat is rising, study says
As temperatures rose in Middle Eastern and North African countries over the last two decades, cancer mortality among women did too, according to a new study of a region that is particularly vulnerable to extreme heat.
The preliminary findings, published Tuesday in the journal Frontiers in Public Health, contribute to a growing body of research on the health effects of temperature and climate change. The scientists looked at breast, ovarian, uterine and cervical cancers among women in 17 countries and discovered what they called a small but significant increase in cases and deaths. The correlation, the authors wrote, comes as climate change increases exposure to cancer risk through heightened ultraviolet radiation and air pollutants.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
an hour ago
- Fast Company
Why the U.K. is betting $76 million on solar engineering to help cool the planet
The climate crisis is worsening. Last year was the warmest on record, global sea ice levels are at a record low, and the economic toll of extreme natural disasters continues to mount. Just this week, the World Meteorological Organization said the global average temperature is likely to rise nearly 2 degrees Celsius above pre-industrial levels within the next five years, with 'growing negative impact on our economies, our daily lives, our ecosystems and our planet.' Experts are adamant that the only way to slow the warming is to stop burning the fossil fuels that create the greenhouse effect. And yet, in 2024, emissions reached a new high. As the WMO's Secretary-General Celeste Saulo put it: 'We are heading in the wrong direction.' And as the temperature rises, so does the chance that Earth's natural systems will cross thresholds that trigger irreversible and cascading destruction. The encroaching threat of these tipping points is why the British government's Advanced Research and Invention Agency (ARIA) is pouring £57 million ($76 million) into studying 'climate cooling approaches.' That's a fancy way of referring to climate geoengineering, or intentionally tinkering with the Earth's weather systems in an attempt to cool things down. More specifically, ARIA is examining whether we might be able to reflect some sunlight away from the surface of the Earth and back into space.
Medscape
an hour ago
- Medscape
Home Healthcare Common for People With Dementia
The use of home healthcare services is common among people with dementia, especially for community-initiated care, a new analysis of Medicare data showed. Between 2010 and 2019, use of community-initiated home healthcare increased by 17%, while use of home healthcare for postacute care rose by 21%. Use decreased after 2020, which investigators said could be linked to staffing shortages in the home healthcare industry. METHODOLOGY: Researchers conducted a cross-sectional analysis, including over 13 million older adults (mean age, 79.4 years; 60% women; 86% White individuals) who were enrolled for traditional Medicare and received home healthcare between 2010 and 2022. The frequency and duration of home healthcare spells were analyzed and compared between individuals with dementia (28%) and those without dementia (72%). Postacute care was defined as home healthcare instituted within 14 days of discharge from a hospital, nursing home, or other facility. All other home healthcare use was classified as community-initiated. TAKEAWAY: Between 2010 and 2022, there were 30,998,653 home healthcare spells (mean, 2.2 home health spells per beneficiary). Individuals with dementia used community-initiated home healthcare more frequently than postacute care (54% vs 46%). Among individuals with dementia, the number of community-initiated care spells increased from 35.4 to 40.2 per 1000 beneficiaries and that of postacute care spells increased from 28.9 to 35.1 per 1000 beneficiaries (2010-2019) and then fell to 33.6 and 28.5 per 1000 beneficiaries by mid-2022, respectively. Between 2010 and 2019, the number of community-initiated care spells among individuals without dementia decreased by 20%, while postacute care spells decreased by 21% in this population. Home healthcare spells were consistently longer for individuals with dementia than those without it (47-52 days vs 44-50 days for community-initiated care and 40-43 days vs 32-34 days for postacute care). IN PRACTICE: 'Despite increasing use of home health care during this time period, people may receive incomplete support for their home healthcare needs through Medicare, which is centered on needs for skilled care, or Medicaid, which entails strict asset and income tests. Decreasing rates of home healthcare use since 2020 in this high-need population point to a need for ongoing monitoring of service use and outcomes for people with dementia,' the investigators wrote. SOURCE: The study was led by Rachel M. Werner, MD, PhD, Perelman School of Medicine, University of Pennsylvania, Philadelphia. It was published online on May 16 in JAMA Network Open . LIMITATIONS: The study relied on claims data for dementia diagnosis. The COVID-19 pandemic may have disrupted healthcare utilization, potentially leading to underdiagnosis of dementia toward the study's end. Additionally, the study only included traditional Medicare beneficiaries as those enrolled in Medicare Advantage typically use home healthcare at lower rates and for shorter periods, which may have influenced the observed trends. DISCLOSURES: The study was funded by the National Institute of Aging. One author reported receiving personal fees from City Block Health and Trinity Health outside the submitted work.
Yahoo
an hour ago
- Yahoo
UAE Prenatal Testing Market to Triple by 2033: Driven by Tech Advancements and Maternal Health Awareness
Key drivers include increasing maternal age, healthcare advancements, and government support for early fetal screening. The market benefits from the rise in medical tourism and global diagnostic partnerships, despite challenges like cultural sensitivities and a lack of genetic counseling. Major players such as Eurofins, Roche, and Illumina enhance the UAE's prenatal care through innovative technologies and strategic partnerships. UAE Non-Invasive Prenatal Testing Market Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "UAE Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to UAE Non-Invasive Prenatal Testing Market is expected to reach US$ 64.46 million by 2033 from US$ 21.04 million in 2024, with a CAGR of 13.25% from 2025 to 2033. The UAE's non-invasive prenatal testing market is growing due to a number of factors, including growing maternal age, better access to healthcare, increasing awareness, government assistance, the need for early fetal screening, and a rise in incidences of genetic disorders. UAE Non-Invasive Prenatal Testing Industry OverviewDue to improvements in genetic screening technology and growing awareness among pregnant parents, the non-invasive prenatal testing (NIPT) market in the United Arab Emirates (UAE) is expanding steadily. NIPT uses a straightforward blood test from the mother to safely and effectively identify chromosomal abnormalities in the fetus. Because of its accuracy, early detection potential, and low danger in comparison to more conventional invasive techniques like amniocentesis, it has becoming more and more popular in the United Arab Emirates. Both public and commercial healthcare organizations are implementing NIPT as a common prenatal screening procedure as healthcare standards rise and prenatal care becomes more maternal age is a major risk factor for chromosomal abnormalities like Down syndrome, which raises the need for accurate prenatal screening and is one of the main causes driving this industry's rise. Furthermore, expanding insurance coverage, the presence of foreign healthcare practitioners, and the UAE government's initiatives to improve genetic health services all help to increase NIPT's accessibility and acceptability. The market is also supported by the nation's growing medical tourism industry, which draws patients from nearby areas looking for cutting-edge prenatal diagnostics, especially in locations like Dubai and Abu its promise, the UAE NIPT industry is beset by issues including low awareness among specific demographic groups and the exorbitant expense of testing for those without insurance. These obstacles are being addressed, meanwhile, by continued public education campaigns, the incorporation of genetics into national healthcare plans, and partnerships with international diagnostics firms. With advancements in bioinformatics and non-invasive technologies anticipated to further improve the precision and reach of prenatal screening services, the NIPT sector in the United Arab Emirates is well-positioned for sustained development as precision medicine continues to Drivers for the UAE Non-Invasive Prenatal Testing Market Supportive Government PoliciesThe UAE's non-invasive prenatal testing (NIPT) sector is expanding thanks in large part to supportive government legislation. As part of its larger national healthcare policy, the government has made maternal and fetal health a top priority, investing heavily in early diagnostic technologies and updating hospital infrastructure. The National Genome Strategy and the UAE's Vision 2031 initiatives center on incorporating cutting-edge genetic technology into standard medical treatment. While regulatory agencies make ensuring that these technologies are used in a safe and moral manner, public health campaigns also seek to increase awareness about prenatal screening. These initiatives, together with advantageous laws and alliances with international biotech companies, are creating a healthcare climate that encourages innovation and the broad use of NIPT throughout the Tourism GrowthThe non-invasive prenatal testing (NIPT) industry in the United Arab Emirates is growing due in large part to the rise of medical tourism, particularly in locations like Dubai and Abu Dhabi. The nation has established itself as a regional center for top-notch, specialized medical treatment, drawing clients from Asia, Africa, and the Middle East. The UAE's highly developed healthcare system, internationally recognized facilities, and access to state-of-the-art diagnostic tools like NIPT attract patients from outside. For pregnant moms looking for early and precise fetal screening, prenatal care facilities that offer individualized attention and minimal wait periods are particularly alluring. The UAE's standing as a destination for cutting-edge prenatal diagnostics is further reinforced by government funding for healthcare tourism and continuous initiatives to enhance service of Global Diagnostic CompaniesOne of the main factors propelling the non-invasive prenatal testing (NIPT) industry's expansion in the United Arab Emirates is the arrival of international diagnostic and genomics firms. To increase access to cutting-edge prenatal screening technology, foreign companies are establishing strategic alliances with regional healthcare providers, labs, and governmental organizations. The accuracy, speed, and scope of NIPT services are improved by these partnerships' introduction of cutting-edge technologies including high-throughput sequencing and AI-powered data processing. Furthermore, foreign actors raise the general level of prenatal care in the United Arab Emirates by assisting with knowledge transfer, workforce training, and adherence to international quality standards. The country's larger objectives of becoming a regional leader in precision healthcare and genomic medicine are supported by this infusion of knowledge and in the UAE Non-Invasive Prenatal Testing Market Cultural and Religious SensitivitiesThe UAE's adoption of non-invasive prenatal testing (NIPT) is significantly hampered by cultural and religious sensitivities. The ethical ramifications of prenatal testing, especially with regard to possible judgments about pregnancy termination, might restrict acceptability in an area where traditional values and religious views are crucial in family and healthcare decisions. Because of religious beliefs about the sanctity of life, worries about disrupting natural processes, or fears of social disapproval, some families might be reluctant to undergo genetic testing. Even when NIPT is advised by a doctor, these issues may cause reluctance to choose it. Building understanding and confidence in prenatal screening necessitates ethical counseling, culturally relevant public education, and collaboration with community and religious of Genetic Counseling ServicesOne major obstacle to the efficient use of non-invasive prenatal testing (NIPT) in the United Arab Emirates is the lack of qualified genetic counselors. Even though NIPT's technology is sophisticated and becoming more widely available, many patients may not have the assistance they need to understand complicated genetic data. Expectant parents may misinterpret test findings without the right counseling, which might cause needless worry or poor choices. In a culturally diverse nation like the United Arab Emirates, where language proficiency and cultural awareness are crucial for successful communication, this disparity is especially significant. Existing healthcare providers are likewise strained by the shortage of skilled workers. To remedy this deficiency, it is imperative to integrate remote or tele-counseling services, expand training programs, and provide incentives for genetic counseling expertise. Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $21 Million Forecasted Market Value (USD) by 2033 $64.5 Million Compound Annual Growth Rate 13.2% Regions Covered United Arab Emirates Report Scope: UAE Non-Invasive Prenatal Testing Market Segment Component Instruments Kits and Reagents Services Application Down Syndrome (Trisomy 21) Edwards Syndrome (Trisomy 18) Patau Syndrome (Trisomy 13) Turner Syndrome Other Applications End User Hospitals Diagnostic Labs The key players have been analyzed by: Overview Key Persons Recent Development & Strategies Financial Insights Key Players Analyzed: Eurofins Scientific F. Hoffmann-La Roche Ltd Invitae Corporation Illumina Inc. Natera Inc. Centogene NV Qiagen For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment UAE Non-Invasive Prenatal Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
